Key opportunities in the Human Metapneumovirus Diagnostics Market include the growing use of multiplex testing panels for ...

The biochips market is projected to expand from USD 14.01 billion in 2025 to USD 21.36 billion by 2030, driven by a CAGR of 8 ...

The proteomics market is experiencing strong growth as demand rises for advanced tools that analyze protein structure, ...

The review emphasizes that differing CLSI and EUCAST breakpoints complicate AMR tracking, calling for standardized criteria ...

The Global Microarrays Market is expected to grow at a CAGR of 7.24% as the demand for drug discovery, disease diagnostics, and precision medicine continues to accelerate.Austin, Texas, Jan. 26, 2026 ...

Pittsburgh, PA — Pitt BioForge and Panther Life Sciences announced the successful completion of BioForge’s first manufacturing project, achieving what had long been considered one of the most ...

Abstract: Microarray data classification is challenged by high dimensionality and small sample sizes, causing feature selection instability. Traditional ensemble feature selection methods struggle to ...

An incorrect Funding statement was provided. The correct Funding statement reads: “The author(s) declare that financial support was received for the research and/or publication of this article. This ...

This R data package provides raw microarray data from three independent lymphoma-related experiments. The data was generated using the Illumina HumanHT-12 microarray platform and comprises primary ...

[Image from the Vaxess website] Vaxess Technologies today shared new preclinical data highlighting the capability of its drug delivery patch to deliver semaglutide. Semaglutide, a GLP-1 receptor ...